Broad-acting therapeutic effects of miR-29b-chitosan on hypertension and diabetic complications

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Christopher J L Murray, Aleksandr Y. Aravkin, Peng Zheng et al. · The Lancet · 2020 · 9.6K citations · Full text

Public Health, Chronic Disease Prevention, Nutrition +17

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

Eva van Rooij, Lillian B. Sutherland, Jeffrey E. Thatcher et al. · Proceedings of the National Academy of Sciences · 2008 · 1.8K citations · Full text

Medicine, Cardiology, Molecular Biology +16

Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters?

PubMed · 1996 · 1.6K citations

Medicine, Cardiology, Surgery +13

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

Christoph Roderburg, Gerd-Willem Urban, Kira Bettermann et al. · Hepatology · 2010 · 787 citations

Life Sciences, Molecular Biology, Pathology +17

RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System

Kenneth A. Howard, Ulrik L. Rahbek, Xiudong Liu et al. · Molecular Therapy · 2006 · 577 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17